English
Insider transactions
EDGARDecibel Therapeutics, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-22.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
This issuer has insider filings in the store, but no transaction in this window or code group.
Latest reported holdings
What each reporting owner last said they hold, as of the date shown. A transaction not yet filed is not in it.
No holding was reported in this window.
Institutional holders (Form 13F)
No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read from their tags. Earlier schedules are free text: they are read only when every cover page states a share count and a percent, and the rest are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| BlackRock, Inc. Common Stock | 7.2 | 1,805,108 | — Filed 2023-02-03 | SC 13GRead from the cover page text | Open filing 0001306550-23-006964 Dispute this row |
| GV 2016, L.P. Common Stock, par value $0.001 per share | 1.29 | 321,978 | — Filed 2022-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-22-040723 Dispute this row |
| GV 2016 GP, L.P. Common Stock, par value $0.001 per share | 1.29 | 321,978 | — Filed 2022-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-22-040723 Dispute this row |
| GV 2016 GP, L.L.C. Common Stock, par value $0.001 per share | 1.29 | 321,978 | — Filed 2022-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-22-040723 Dispute this row |
| GV 2017, L.P. Common Stock, par value $0.001 per share | 1.98 | 494,649 | — Filed 2022-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-22-040723 Dispute this row |
| GV 2017 GP, L.P. Common Stock, par value $0.001 per share | 1.98 | 494,649 | — Filed 2022-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-22-040723 Dispute this row |
| GV 2017 GP, L.L.C. Common Stock, par value $0.001 per share | 1.98 | 494,649 | — Filed 2022-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-22-040723 Dispute this row |
| GV 2019, L.P. Common Stock, par value $0.001 per share | 3.29 | 819,631 | — Filed 2022-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-22-040723 Dispute this row |
| GV 2019 GP, L.P. Common Stock, par value $0.001 per share | 3.29 | 819,631 | — Filed 2022-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-22-040723 Dispute this row |
| GV 2019 GP, L.L.C. Common Stock, par value $0.001 per share | 3.29 | 819,631 | — Filed 2022-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-22-040723 Dispute this row |
| Alphabet Holdings LLC Common Stock, par value $0.001 per share | 6.57 | 1,636,258 | — Filed 2022-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-22-040723 Dispute this row |
| XXVI Holdings Inc. Common Stock, par value $0.001 per share | 6.57 | 1,636,258 | — Filed 2022-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-22-040723 Dispute this row |
| Alphabet Inc. Common Stock, par value $0.001 per share | 6.57 | 1,636,258 | — Filed 2022-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-22-040723 Dispute this row |
| Third Rock Ventures III, L.P. COMMON STOCK, $0.001 PAR VALUE PER SHARE | 12.6 | 3,139,685 | — Filed 2022-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-22-042110 Dispute this row |
| Third Rock Ventures GP III, L.P. COMMON STOCK, $0.001 PAR VALUE PER SHARE | 12.6 | 3,139,685 | — Filed 2022-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-22-042110 Dispute this row |
| TRV GP III, LLC COMMON STOCK, $0.001 PAR VALUE PER SHARE | 12.6 | 3,139,685 | — Filed 2022-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-22-042110 Dispute this row |
| Mark Levin COMMON STOCK, $0.001 PAR VALUE PER SHARE | 12.6 | 3,139,685 | — Filed 2022-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-22-042110 Dispute this row |
| Kevin P. Starr COMMON STOCK, $0.001 PAR VALUE PER SHARE | 12.6 | 3,139,685 | — Filed 2022-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-22-042110 Dispute this row |
| Robert I. Tepper COMMON STOCK, $0.001 PAR VALUE PER SHARE | 12.6 | 3,139,685 | — Filed 2022-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-22-042110 Dispute this row |
| REGENERON PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share | 8.42 | 2,097,314 | — Filed 2022-02-11 | SC 13GRead from the cover page text | Open filing 0001104659-22-020463 Dispute this row |
| OrbiMed Advisors LLC Common Stock | 16.7 | 4,061,774 | — Filed 2021-03-02 | SC 13DRead from the cover page text | Open filing 0000947871-21-000278 Dispute this row |
| OrbiMed Capital GP VIII LLC Common Stock | 15.8 | 3,843,206 | — Filed 2021-03-02 | SC 13DRead from the cover page text | Open filing 0000947871-21-000278 Dispute this row |
| OrbiMed Genesis GP LLC Common Stock | 0.9 | 218,568 | — Filed 2021-03-02 | SC 13DRead from the cover page text | Open filing 0000947871-21-000278 Dispute this row |
| OrbiMed Capital LLC Common Stock | 3.6 | 883,418 | — Filed 2021-03-02 | SC 13DRead from the cover page text | Open filing 0000947871-21-000278 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
3,092,627 filings read, dated 1980-01-02 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 246,723 |
| 2016 | 246,472 |
| 2017 | 244,814 |
| 2018 | 245,575 |
| 2019 | 238,619 |
| 2020 | 249,093 |
| 2021 | 274,850 |
| 2022 | 257,922 |
| 2023 | 253,676 |
| 2024 | 261,106 |
| 2025 | 235,525 |
| 2026 | 263,830 |
Filings made before the SEC required XML are listed, not extracted.